Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

NCT01356602 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Gouty Arthritis

Interventions

DRUG: Canakinumab pre-filled syringe
DRUG: Canakinumab lyophilized powder
DRUG: Triamcinolone Acetonide
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals